Samples:
4 samples of 1.5 ml
Sample properties:
Lyophilised cell culture material
Additional Information:
The requirements of the RiliBÄK (Guidelines of the German Medical Association on quality assurance in medical laboratory testing / Bundesärztekammer) will be considered for the detection of the above-mentioned pathogens.
This EQA scheme will contain each of the above-mentioned pathogens at least once a year. It is recommended to participate at both EQA scheme terms.
Please note:
Only results of multiplex tests will be accepted for EQA scheme 431
This multiplex EQA scheme is not suitable for (i) singleplex PCRs, (ii) tests for antigen detection, (iii) testing of sensitivity and (iv) typing. For this purpose, we refer to the INSTAND EQA schemes for the corresponding viruses.
Orders for EQA schemes from non-EU countries can only be processed by INSTAND e.V. if the ordering laboratories provide a fully completed end-use declaration, a company profile including contact details (e.g. an extract from the website) and, where applicable, an import licence! If these documents are not received by the registration/withdrawal deadline, the registration will unfortunately have to be cancelled. Please also note the dispatch information in this regard.
Requirement for EQAS/PT according to Rili-BÄK
Certificate Validity: 12 months
Not subject to Rili-BÄK
Parameters: Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for simultaneous qualitative detection of respiratory adeno, boca, corona, entero, human metapneumo, human rhino, influenza A and B viruses incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively.
This program will be completed with currently circulating virus variants.
Some of the samples can contain chemically inactivated avian influenza A viruses.
Certificate Validity: 12 months
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material. The participating laboratory must be authorized to perform direct and/or indirect detection of pathogens.
Dates:
Registration deadline:
Sample shipment:
Closing Date:
EQAS/PT Experts:
Dr. rer. nat. Rolf Kaiser, Dipl.-Biol.
Institut für Virologie
Universität und Universitätsklinikum zu Köln
Fürst-Pückler-Straße 56
50935 Köln
+49 221 478-85808
rolf.kaiser@uk-koeln.de
Dr. rer. nat. Martin Kammel
Institut für Qualitätssicherung in der Virusdiagnostik - IQVD
Potsdamer Chaussee 80
14129 Berlin
+49 30 8105 4300
m.kammel@iqvd.de
